Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP781854.RAI_XUjSJQUUgg4oFcaaWQUWsM5wvB1xV3XiCDQCwvfuQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP781854.RAI_XUjSJQUUgg4oFcaaWQUWsM5wvB1xV3XiCDQCwvfuQ130_assertion type Assertion NP781854.RAI_XUjSJQUUgg4oFcaaWQUWsM5wvB1xV3XiCDQCwvfuQ130_head.
- NP781854.RAI_XUjSJQUUgg4oFcaaWQUWsM5wvB1xV3XiCDQCwvfuQ130_assertion description "[The mammalian target of rapamycin, which is a sensor of the mitochondrial transmembrane potential, has been successfully targeted for treatment of SLE with rapamycin or sirolimus in both patients and animal models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781854.RAI_XUjSJQUUgg4oFcaaWQUWsM5wvB1xV3XiCDQCwvfuQ130_provenance.
- NP781854.RAI_XUjSJQUUgg4oFcaaWQUWsM5wvB1xV3XiCDQCwvfuQ130_assertion evidence source_evidence_literature NP781854.RAI_XUjSJQUUgg4oFcaaWQUWsM5wvB1xV3XiCDQCwvfuQ130_provenance.
- NP781854.RAI_XUjSJQUUgg4oFcaaWQUWsM5wvB1xV3XiCDQCwvfuQ130_assertion SIO_000772 20014960 NP781854.RAI_XUjSJQUUgg4oFcaaWQUWsM5wvB1xV3XiCDQCwvfuQ130_provenance.
- NP781854.RAI_XUjSJQUUgg4oFcaaWQUWsM5wvB1xV3XiCDQCwvfuQ130_assertion wasDerivedFrom befree-2016 NP781854.RAI_XUjSJQUUgg4oFcaaWQUWsM5wvB1xV3XiCDQCwvfuQ130_provenance.
- NP781854.RAI_XUjSJQUUgg4oFcaaWQUWsM5wvB1xV3XiCDQCwvfuQ130_assertion wasGeneratedBy ECO_0000203 NP781854.RAI_XUjSJQUUgg4oFcaaWQUWsM5wvB1xV3XiCDQCwvfuQ130_provenance.